The identification of path_BRCA1 or path_BRCA2 in an affected BC individual enables access to evidence-based screening for family members, and thus facilitates the implementation of appropriate cancer prevention in these families [1, 5, 6]. The gene discussed is BRCA1; the disease is cancer.